Validation of the Keele STarT MSK Tool for Patients with Musculoskeletal Pain in United States-Based Outpatient Physical Therapy Settings
Jason M. Beneciuk,Lori A. Michener,Erica Sigman,Trent Harrison,Katherine E. Buzzanca-Fried,Xinlin Lu,Guogen Shan,Jonathan C. Hill
DOI: https://doi.org/10.1016/j.jpain.2024.01.340
IF: 5.383
2024-01-19
Journal of Pain
Abstract:The STarT MSK tool was developed to enable risk stratification of patients with common musculoskeletal (MSK) pain conditions and help identify individuals who may require more targeted interventions or closer monitoring in primary care settings, however its validity in US-based outpatient physical therapy settings has not been investigated. The 10-item Keele STarT MSK risk stratification tool was tested for construct (convergent and discriminant) and predictive validity using a multicenter, prospective cohort study design. Participants (n=141) receiving physical therapy for MSK pain of the back, neck, shoulder, hip, knee, or multisite regions completed intake questionnaires including the Keele STarT MSK tool, Functional Comorbidity Index (FCI), OSPRO-ROS and OSPRO-YF tools. Pain intensity, pain interference, and health related quality of life (SF-8 physical [PCS] and mental [MCS] component scores) were measured at 2- and 6-month follow-up. Participants were classified as STarT MSK tool low (44%), medium (39%), and high (17%) risk. Follow-up rates were 70.2% (2 months) and 49.6% (6 months). For convergent validity, fair relationships were observed between the STarT MSK tool and FCI and SF-8 MCS (r = 0.35-0.37) while moderate-to-good relationships (r = 0.51-0.72) were observed for seven other clinical measures. For discriminant validity, STarT MSK tool risk dependent relationships were observed for OSPRO-ROS, OSPRO-YF, pain interference, and SF-8 PCS (low<medium<high; (11.2%,20.0%),="" (7.5%,14.1%),="" (8.2%,12.8%)="" (low<medium-or-high;="" 2-="" 6-months,="" additional="" and="" at="" by="" construct="" contributes="" cross-sectional="" evidence="" existing="" explained="" fci,="" for="" in="" intake="" intensity="" intensity,="" interference="" literature="" longitudinal="" mcs="" msk="" of="" p="" p<0.01)="" p<0.01).="" pain="" pcs="" predictive="" providing="" respectively.="" scores="" sf-8="" start="" study="" this="" to="" tool="" validity="" validity,="" validity. Perspective This study presents STarT MSK risk stratification tool validity findings from a US outpatient physical therapy sample. The STarT MSK tool has potential to help physical therapists identify individuals presenting with the most common MSK pain conditions who may require more targeted interventions or closer monitoring. </medium
neurosciences,clinical neurology